BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11789762)

  • 1. Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer.
    Lai WW; Chen FF; Wu MH; Chow NH; Su WC; Ma MC; Su PF; Chen H; Lin MY; Tseng YL
    Ann Thorac Surg; 2001 Dec; 72(6):1868-76. PubMed ID: 11789762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the epidermal growth factor system in endometrial cancer.
    Adonakis G; Androutsopoulos G; Koumoundourou D; Liava A; Ravazoula P; Kourounis G
    Eur J Gynaecol Oncol; 2008; 29(5):450-4. PubMed ID: 19051810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis.
    Hilbe W; Dirnhofer S; Oberwasserlechner F; Eisterer W; Ammann K; Schmid T; Hilbe G; Thaler J; Wöll E
    J Clin Pathol; 2003 Oct; 56(10):736-41. PubMed ID: 14514775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialomucin expression is associated with erbB-2 oncoprotein overexpression, early recurrence, and cancer death in non-small-cell lung cancer.
    Yu CJ; Shun CT; Yang PC; Lee YC; Shew JY; Kuo SH; Luh KT
    Am J Respir Crit Care Med; 1997 Apr; 155(4):1419-27. PubMed ID: 9105088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer.
    Kashihara M; Azuma K; Kawahara A; Basaki Y; Hattori S; Yanagawa T; Terazaki Y; Takamori S; Shirouzu K; Aizawa H; Nakano K; Kage M; Kuwano M; Ono M
    J Thorac Oncol; 2009 Sep; 4(9):1066-74. PubMed ID: 19648825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of anoctamin 1 is associated with advanced tumor stage in patients with non-small cell lung cancer and predicts recurrence after surgery.
    He Y; Li H; Chen Y; Li P; Gao L; Zheng Y; Sun Y; Chen J; Qian X
    Clin Transl Oncol; 2017 Sep; 19(9):1091-1098. PubMed ID: 28299581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative multiplexed analysis of ErbB family coexpression for primary breast cancer prognosis in a large retrospective cohort.
    Giltnane JM; Moeder CB; Camp RL; Rimm DL
    Cancer; 2009 Jun; 115(11):2400-9. PubMed ID: 19330842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival.
    Akslen LA; Varhaug JE
    Cancer; 1995 Nov; 76(9):1643-54. PubMed ID: 8635070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-recurrence survival analysis of stage I non-small-cell lung cancer.
    Lee K; Kim HR; Kim DK; Kim YH; Park SI; Choi SH; Han J
    Asian Cardiovasc Thorac Ann; 2017 Nov; 25(9):623-629. PubMed ID: 29058973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in non-small cell lung cancer.
    Cheng TL; Chang MY; Huang SY; Sheu CC; Kao EL; Cheng YJ; Chong IW
    Chest; 2005 Sep; 128(3):1453-60. PubMed ID: 16162743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localized adenocarcinoma of the lung: oncogene expression of erbB-2 and p53 in 150 patients.
    Harpole DH; Marks JR; Richards WG; Herndon JE; Sugarbaker DJ
    Clin Cancer Res; 1995 Jun; 1(6):659-64. PubMed ID: 9816029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent overexpression of ErbB--receptor family members in brain metastases of non-small cell lung cancer patients.
    Berghoff AS; Magerle M; Ilhan-Mutlu A; Dinhof C; Widhalm G; Dieckman K; Marosi C; Wöhrer A; Hackl M; Zöchbauer-Müller S; Preusser M; Birner P
    APMIS; 2013 Dec; 121(12):1144-52. PubMed ID: 23756255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression.
    Ohsaki Y; Tanno S; Fujita Y; Toyoshima E; Fujiuchi S; Nishigaki Y; Ishida S; Nagase A; Miyokawa N; Hirata S; Kikuchi K
    Oncol Rep; 2000; 7(3):603-7. PubMed ID: 10767376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and activation of erbB-2 and epidermal growth factor receptor in lung adenocarcinomas.
    Rachwal WJ; Bongiorno PF; Orringer MB; Whyte RI; Ethier SP; Beer DG
    Br J Cancer; 1995 Jul; 72(1):56-64. PubMed ID: 7599067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
    He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L
    J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytochemical markers in stage I lung cancer: relevance to prognosis.
    Pastorino U; Andreola S; Tagliabue E; Pezzella F; Incarbone M; Sozzi G; Buyse M; Menard S; Pierotti M; Rilke F
    J Clin Oncol; 1997 Aug; 15(8):2858-65. PubMed ID: 9256129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
    Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
    Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression.
    Harpole DH; Herndon JE; Wolfe WG; Iglehart JD; Marks JR
    Cancer Res; 1995 Jan; 55(1):51-6. PubMed ID: 7805040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections.
    Pfeiffer P; Clausen PP; Andersen K; Rose C
    Br J Cancer; 1996 Jul; 74(1):86-91. PubMed ID: 8679464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal-like immunophenotype markers and prognosis in early breast cancer.
    Cassol L; Silveira Graudenz M; Zelmanowicz A; Cancela A; Werutsky G; Rovere RK; Garicochea B
    Tumori; 2010; 96(6):966-70. PubMed ID: 21388060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.